{"id":"W4410897749","doi":"10.1186/s13063-025-08895-7","title":"A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS)","year":2025,"lang":"en","type":"article","venue":"Trials","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Population Health Research Institute","funders":"Alexion Pharmaceuticals; AstraZeneca","keywords":"Medicine; Acute kidney injury; Kidney disease; Kidney; Adverse effect; Intensive care medicine; Disease; Bioinformatics; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002924455,0.001854539,0.002308611,0.0004685942,0.0006214769,0.001292334,0.0009928311,0.002084304,0.005569893],"category_scores_gemma":[0.001998714,0.0006329137,0.002534662,0.0003458117,0.001014808,0.001079704,0.0004288839,0.004087887,0.001057137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007269204,"about_ca_system_score_gemma":0.002260317,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008840945,"about_ca_topic_score_gemma":0.001983306,"domain_scores_codex":[0.9993405,0.0003330887,0.0000297748,0.0001033092,0.00006059929,0.0001326942],"domain_scores_gemma":[0.9986048,0.0002796258,0.0003221854,0.0001363892,0.0001377056,0.0005192913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8869293,0.04828676,0.001982271,0.001251414,0.001954826,0.0001932707,0.0002137781,0.001003284,0.01981632,0.0003455587,0.004041277,0.033982],"study_design_scores_gemma":[0.8724617,0.1218046,0.002801663,0.00003701464,0.000353181,0.00009703354,0.00002197546,0.0003869233,0.0007971587,0.0001925393,0.001029345,0.0000167863],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9746003,0.004459428,0.001729017,0.001648226,0.0005128777,0.01108898,0.002676784,0.0003048754,0.002979419],"genre_scores_gemma":[0.9638937,0.003447641,0.00574021,0.004275977,0.0005475393,0.01460247,0.00367657,0.0000737413,0.003742159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005569893,"threshold_uncertainty_score":0.01863319,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03456718329314373,"score_gpt":0.3734508033537506,"score_spread":0.3388836200606068,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}